FDA Approved: RETEVMO — Original Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved the original application for selpercatinib (RETEVMO) from Eli Lilly and Company. It is approved for RET fusion-positive non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Thyroid Cancer

Drugs mentioned

• RETEVMO (selpercatinib)

Snippet

ORIG AP for RETEVMO (SELPERCATINIB)